Analyze Diet
Journal of the American Veterinary Medical Association2000; 217(10); 1514-1521; doi: 10.2460/javma.2000.217.1514

Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses.

Abstract: To evaluate clinical safety of administration of injectable enrofloxacin. Methods: Randomized controlled clinical trial. Methods: 24 adult horses. Methods: Healthy horses were randomly allocated into 4 equal groups that received placebo injections (control) or IV administration of enrofloxacin (5 mg/kg [2.3 mg/lb], 15 mg/kg [6.8 mg/lb], or 25 mg/kg [11.4 mg/lb] of body weight, q 24 h) for 21 days. Joint angles, cross-sectional area of superficial and deep digital flexor and calcaneal tendons, carpal or tarsal osteophytes or lucency, and midcarpal and tarsocrural articular cartilage lesions were measured. Physical and lameness examinations were performed daily. Measurements were repeated after day 21, and articular cartilage and bone biopsy specimens were examined. Results: Enrofloxacin did not induce changes in most variables during administration or for 7 days after administration. One horse (dosage, 15 mg/kg) developed lameness and cellulitis around the tarsal plantar ligament during the last week of administration. One horse (dosage, 15 mg/kg) developed mild superficial digital flexor tendinitis, and 1 horse (dosage, 25 mg/kg) developed tarsal sheath effusion without lameness 3 days after the last administration. High doses of enrofloxacin (15 and 25 mg/kg) administered by bolus injection intermittently induced transient neurologic signs that completely resolved within 10 minutes without long-term effects. Slower injection and dilution of the dose ameliorated the neurologic signs. Adverse reactions were not detected with a 5 mg/kg dose administered IV as a bolus. Conclusions: Enrofloxacin administered IV once daily at the rate of 5 mg/kg for 3 weeks is safe in adult horses.
Publication Date: 2000-01-11 PubMed ID: 11128543DOI: 10.2460/javma.2000.217.1514Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study assesses the clinical safety of long-term usage of injectable enrofloxacin, an antibiotic, in adult horses. The researchers conducted randomized controlled clinical trials with 24 horses and concluded that administering enrofloxacin intravenously at a rate of 5 mg/kg once daily for 3 weeks is safe for adult horses.

Research Method

  • The researchers enrolled 24 healthy adult horses in this randomized controlled clinical trial.
  • The horses were randomly divided into four equal groups. One group received a placebo, while the other three were given different doses of IV enrofloxacin (5mg/kg, 15mg/kg, or 25mg/kg of body weight once every 24 hours) for 21 days.
  • Several physical and musculoskeletal variables were monitored, including joint angles, cross-sectional areas of tendons, the presence of osteophytes or articular cartilage lesions, and daily physical and lameness examinations.
  • Measurements were repeated on day 21, and articular cartilage and bone biopsy specimens were examined.

Results

  • Overall, enrofloxacin did not induce changes in most of the evaluated variables either during administration or for 7 days after administration.
  • However, at higher doses (15 and 25 mg/kg), some adverse effects were observed. One horse developed lameness and cellulitis around the tarsal plantar ligament, and another showed signs of mild superficial digital flexor tendinitis. Another horse developed tarsal sheath effusion without lameness three days after the last administration.
  • Interestingly, high doses of enrofloxacin given intermittently caused transient neurologic signs, which resolved completely within 10 minutes and had no long-term effects. These signs were mitigated by slower injection and dilution of the dose.
  • No adverse reactions were detected when using a 5 mg/kg dose administered intravenously as a single injection.

Conclusions

  • In conclusion, the study determined that IV administration of enrofloxacin at a dose of 5 mg/kg once daily for 21 days is safe in adult horses.
  • Higher doses showed some negative effects and thus should be administered with caution, especially considering the temporary neurologic signs noted with bolus injection.

Cite This Article

APA
Bertone AL, Tremaine WH, Macoris DG, Simmons EJ, Ewert KM, Herr LG, Weisbrode SE. (2000). Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses. J Am Vet Med Assoc, 217(10), 1514-1521. https://doi.org/10.2460/javma.2000.217.1514

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 217
Issue: 10
Pages: 1514-1521

Researcher Affiliations

Bertone, A L
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus 43210, USA.
Tremaine, W H
    Macoris, D G
      Simmons, E J
        Ewert, K M
          Herr, L G
            Weisbrode, S E

              MeSH Terms

              • Animals
              • Anti-Infective Agents / administration & dosage
              • Anti-Infective Agents / adverse effects
              • Anti-Infective Agents / pharmacology
              • Biopsy / veterinary
              • Blood Cell Count
              • Blood Chemical Analysis
              • Bone and Bones / pathology
              • Cartilage, Articular / pathology
              • Enrofloxacin
              • Evaluation Studies as Topic
              • Female
              • Fluoroquinolones
              • Horses / physiology
              • Injections / veterinary
              • Joints / diagnostic imaging
              • Joints / physiology
              • Lameness, Animal
              • Male
              • Muscle, Skeletal / drug effects
              • Quinolones / administration & dosage
              • Quinolones / adverse effects
              • Quinolones / pharmacology
              • Radiography / veterinary
              • Ultrasonography

              Citations

              This article has been cited 6 times.
              1. Santifort KM. Head rebound test in the clinical neurological examination of veterinary patients: a case example and discussion of Stewart and Holmes' rebound phenomenon. Front Vet Sci 2023;10:1180132.
                doi: 10.3389/fvets.2023.1180132pubmed: 37292429google scholar: lookup
              2. Celani G, Tulini SMR, Montesano C, Zezza D, Sergi M, Varasano V, Mortellaro CM, Compagnone D, Amorena M, Petrizzi L. Pharmacokinetics of marbofloxacin administered via intravenous regional limb perfusion in dairy cows: evaluation of two different tourniquets. Vet Rec Open 2017;4(1):e000227.
                doi: 10.1136/vetreco-2017-000227pubmed: 29018533google scholar: lookup
              3. Endo Y, Tsuchiya T, Omura T, Nakai K, Korosue K, Ishimaru M, Ishikawa Y, Hobo S. Effects of pre-shipping marbofloxacin administration on fever and blood properties in healthy Thoroughbreds transported a long distance. J Vet Med Sci 2015 Jan;77(1):75-9.
                doi: 10.1292/jvms.14-0336pubmed: 25720808google scholar: lookup
              4. Hwang YH, Kim MS, Song IB, Lim JH, Park BK, Yun HI. Altered pharmacokinetics of enrofloxacin in experimental models of hepatic and renal impairment. Vet Res Commun 2009 Jun;33(5):481-7.
                doi: 10.1007/s11259-008-9195-ypubmed: 19085067google scholar: lookup
              5. Adams AR, Haines GR, Brown MP, Gronwall R, Merritt K. Pharmacokinetics of difloxacin and its concentration in body fluids and endometrial tissues of mares after repeated intragastric administration. Can J Vet Res 2005 Jul;69(3):229-35.
                pubmed: 16187554
              6. Haines GR, Brown MP, Gronwall RR, Merritt KA, Baltzley LK. Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Can J Vet Res 2001 Jul;65(3):181-7.
                pubmed: 11480524